Today’s Market Runner: Could Allscripts Healthcare Solutions Inc See a Reversal After This Very Weak Session?

Today's Market Runner: Could Allscripts Healthcare Solutions Inc See a Reversal After This Very Weak Session?

The stock of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) is a huge mover today! About 1.92 million shares traded hands. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has risen 4.53% since March 8, 2016 and is uptrending. It has underperformed by 4.79% the S&P500.
The move comes after 7 months negative chart setup for the $2.45 billion company. It was reported on Oct, 11 by Barchart.com. We have $11.79 PT which if reached, will make NASDAQ:MDRX worth $196.00 million less.

Analysts await Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to report earnings on November, 3. They expect $0.11 earnings per share, up 10.00% or $0.01 from last year’s $0.1 per share. MDRX’s profit will be $21.02 million for 29.14 P/E if the $0.11 EPS becomes a reality. After $0.10 actual earnings per share reported by Allscripts Healthcare Solutions Inc for the previous quarter, Wall Street now forecasts 10.00% EPS growth.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) Ratings Coverage

Out of 16 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 10 rate it a “Buy”, 0 “Sell”, while 6 “Hold”. This means 63% are positive. Allscripts-Misys Healthcare has been the topic of 24 analyst reports since August 5, 2015 according to StockzIntelligence Inc. The firm has “Neutral” rating by Citigroup given on Friday, May 13. The rating was initiated by JP Morgan with “Overweight” on Tuesday, November 17. The stock of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has “Buy” rating given on Friday, October 16 by Jefferies. The stock has “Outperform” rating given by RBC Capital Markets on Friday, February 19. The firm earned “Outperform” rating on Tuesday, August 23 by Leerink Swann. Argus Research maintained the shares of MDRX in a report on Friday, January 22 with “Buy” rating. The rating was maintained by RBC Capital Markets on Wednesday, August 5 with “Sector Perform”. Morgan Stanley upgraded the stock to “Overweight” rating in Wednesday, March 30 report. As per Monday, August 24, the company rating was upgraded by Argus Research. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, January 7.

According to Zacks Investment Research, “Allscripts Healthcare Solutions, Inc. offers clinical software, services, information and connectivity solutions that enable physicians and healthcare providers to deliver patients safety and clinical outcomes in the US. The Company provides intuitive clinical and business solutions including Electronic Health Records, practice management, revenue cycle management, document management, electronic prescribing, clinical trials and services for small to mid-sized practices. It also provides advanced clinical and business solutions including Electronic Health Records, practice management, revenue cycle management, document management, electronic prescribing, clinical trials and optimization services for large physician practices, academic medical centers and hospitals. In addition, the Company’s Health Systems Group has Emergency Department and care management systems for hospitals, as well as homecare and referral management solutions for post-acute providers. Allscripts is headquartered in Chicago, Illinois.”

Insitutional Activity: The institutional sentiment decreased to 1.25 in 2016 Q2. Its down 0.13, from 1.38 in 2016Q1. The ratio dropped, as 27 funds sold all Allscripts Healthcare Solutions Inc shares owned while 64 reduced positions. 25 funds bought stakes while 89 increased positions. They now own 185.59 million shares or 2.43% less from 190.21 million shares in 2016Q1.
Aqr Ltd Liability Com accumulated 0.02% or 743,610 shares. Ls Investment Limited Co holds 12,246 shares or 0.01% of its portfolio. Wellington Management Gru Ltd Liability Partnership last reported 0.09% of its portfolio in the stock. State Street Corp last reported 0.01% of its portfolio in the stock. Continental Advsr Ltd Liability Co holds 73,323 shares or 0.29% of its portfolio. Manufacturers Life Ins The accumulated 0% or 252,436 shares. Cortina Asset Mngmt Lc reported 493,158 shares or 0.28% of all its holdings. Credit Suisse Ag, a Switzerland-based fund reported 254,564 shares. Panagora Asset Management holds 0.02% or 361,706 shares in its portfolio. Iridian Asset Mgmt Limited Liability Corporation Ct holds 1.17% or 9.97M shares in its portfolio. The Texas-based Capstone Asset Mgmt Com has invested 0.01% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Parametric Portfolio Associates Ltd Llc reported 107,451 shares or 0% of all its holdings. Ubs Asset Mgmt Americas accumulated 0% or 144,761 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest accumulated 63,200 shares or 0.01% of the stock. New York State Common Retirement Fund, a New York-based fund reported 949,505 shares.

Insider Transactions: Since June 13, 2016, the stock had 0 insider purchases, and 7 selling transactions for $1.20 million net activity. 15,000 shares were sold by Black Paul, worth $195,000 on Thursday, September 15. HEWITT JAMES sold $227,500 worth of stock. Another trade for 10,000 shares valued at $130,300 was made by Poulton Richard J. on Monday, June 13. Shares for $98,000 were sold by Olis Dennis.

MDRX Company Profile

Allscripts Healthcare Solutions, Inc., incorporated on July 11, 2000, delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Firm operates through two divisions: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services. The Company’s Population Health segment includes the sale of health management and coordinated care solutions, which are mainly focused on hospitals, health systems, other care facilities and accountable care organizations (ACOs). These solutions enable clients to connect, transition, analyze, and coordinate care across the care community.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment